Innovation is often romanticized as a solitary pursuit—the “aha” moment in a lab or a garage. But in digital health, the reality is different. Real transformation happens at the intersections: where startups meet pharma, where clinicians meet coders, and where regulation meets agility.

We were inspired by a recent update from Luigi Pavia, a key figure in the Frontiers Health community. His insights reminded us why we are so proud to be an active part of this ecosystem.

As we prepare to head to Berlin in just a couple of weeks, we are reflecting on the value of these connections.

Why the “Ecosystem” Matters

When we talk about the “Frontiers Health Ecosystem,” we aren’t just using a buzzword. We are describing a necessary infrastructure for survival and scale.

Developing digital therapeutics—like our solutions for chronic pain (Rohkea) or Parkinson’s (Soturi)—is complex. No single company has all the answers regarding reimbursement, adoption, and tech stacks.

• We need the investors who understand long-term value over short-term hype.
• We need the pharma partners looking to extend their portfolios “beyond the pill.”
• We need the policy experts shaping the future of HTA (Health Technology Assessment).

Luigi and the Frontiers team have built a platform where these silos dissolve, allowing companies like Newel Health to find the partners necessary to bring our H. Core platform to more patients globally.

The Road to Berlin

We look forward to seeing our ecosystem partners and collaborators in Berlin.

For Newel Health, this upcoming gathering is about moving from conversation to calibration. We are eager to validate our strategies against the market’s best minds and to explore new avenues for collaboration.

If you are part of this vibrant community and will be in Berlin, let’s ensure we connect. We are ready to share our learnings, listen to yours, and continue building the future of health, together.

See you in Berlin!